Global Drug Transfer Device Market by Types (Membrane-to-Membrane Systems and Needleless Systems), Components (Closed Bag/Line Access Devices, Closed Vial Access Devices, and Closed Syringe Safety Devices), Technology (Diaphragm-Based Devices, Compartmentalized Devices, and Air Cleaning/Filtration Devices), End-users (Specialty Centers, Hospitals, Clinics, and Others), and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2020 - 2027
Drug Transfer Device Market Outlook
The global drug transfer device market was valued at USD 392.6 Mn in 2019 and is projected to reach USD 1,767.4 Mn by 2027, expanding at a CAGR of 21.2% during the forecast period. The market is driven by the rising number of cancer cases and increasing adoption of chemotherapy are anticipated to drive the demand for the drug transfer device market. Growth of drug transfer devices is attributed to combat the harmful effects of antineoplastic drugs.
Drug transfer device mechanically forbids the transfer of environmental impurities into the system and the escape of the hazardous drug. The drug transfer devices are those which prevent drug leak at the time of patient treatment. The drug leak can take place at the time of reconstitution, administration of the drug to the patient or compounding.
Pharmacists, physicians, nurses, and other healthcare workers come in contact with several hazardous drugs, such as antineoplastics, monoclonal antibodies, and antibiotics during cancer treatments. Adoption of drug transfer devices has witnessed growth, as it reduces surface contamination and closes routes of exposure.
Drug Transfer Device Market Dynamics
Drug transfer devices are devices designed to prevent the transfer of contaminants into the environment during drug transfer between the vial and syringe, by maintaining a closed connection. Rising number of cancer cases and increasing adoption of chemotherapy are anticipated to drive the demand for the drug transfer device market.
Pharmacists, physicians, nurses, and other healthcare workers come in contact with several hazardous drugs, such as antineoplastics, monoclonal antibodies, and antibiotics during cancer treatments. Traces of these drugs have been found in unlikely places like doorknobs, keyboards, and other surfaces. It also affects the patients and their families and other hospital staff.
Recent discoveries in cancer and oncology has led to new treatment approaches and drugs. Yet cancer exists with unmet medical needs. Regulatory authorities such as the FDA have now begun to show flexibility towards the approval of drugs and have come up with new and creative ways of measuring the suitability of cancer drugs. This has led to a substantial surge in the speed of approval of new drugs.
Vial adaptor is a drug transfer device that connects vial to syringe or vial to vial, enabling the mixing and/or transfer of the drug (to be administered to the patient thereafter). Although there are many ISO standards for infusion transfer devices, these do not necessarily apply to vial adaptors. When healthcare sites criticize about issues with vial adaptors, no standards exist to support the issues. Vial adaptor manufacturers want to design products that achieve user and patient safety, but lack quantitative specifications to test their devices in real-world conditions.
Hence, lack of detailed guidelines and inefficiency of drug transfer products especially in emerging nations and restrain the market. According to National Medical Products Administration, around 10 million healthcare personnel in China are exposed to hazardous drugs annually, due to lack of government policies and proper guidelines regarding drug transfer devices.
Drug transfer devices are additional engineering controls designed to reduce occupational exposure of hazardous drugs. They are constantly implemented in accordance with changing regulations. A significant number of drug transfer devices are now commercially available. They comprise different materials of construction, lubricants, fluid path, and holdup volumes.
A detailed compatibility study with each type of commercial drug transfer device and investigational drug products is difficult and significantly extends timelines for product development. Health authority feedback regarding the use of drug transfer devices for investigational drug products is needed to ensure compliance, especially for patient safety while balancing risk and benefit to the health care personnel. This is expected to provide opportunities for market growth.
Drug Transfer Device Market Segmental Outlook
Based on types, the global drug transfer device market is segmented into membrane-to-membrane systems and needleless systems. The membrane-to-membrane segment is expected to grow at a significant rate during the forecast period. The presence of double membrane for transfusion of medication provides an added layer of protection compared to needleless membranes, which fuels the membrane-to-membrane segment.
In terms of components, the global drug transfer device market is segmented into closed bag/line access devices, closed vial access devices, and closed syringe safety devices. The closed vial access devices segment is estimated to expand during the forecast period. Closed vial access devices help in storing a drug for up to a week. The closed vial access device segment is expected to grow at a substantial pace during the forecast period.
Based on technologies, the global drug transfer device market is segmented into diaphragm-based devices, compartmentalized devices, and air cleaning/filtration devices. The diaphragm-based devices segment is anticipated to expand at a significant pace in the coming years. The diaphragm-based devices segment dominated the market during 2019 and held a key share of the market.
The segment is projected to expand at a considerable pace during the forecast period owing to the safety provided by these device and ease of operation. The compartmentalized devices segment is estimated to expand at a rapid pace due to its cost-effectiveness.
In terms of end-users, the global drug transfer device market is segregated into specialty centers, hospitals, clinics, and others. The hospitals segment is expected to lead the market during forecast, as patients prefer to visit hospitals due to the presence of doctors and medical staff and equipment for treatment under one roof. Accessibility of diagnostic centers in the clinic is helpful for patients as they can be diagnosed and tested at the same place. The clinics are less expensive.
However, non-availability of services 24*7 may hinder the growth of clinic segment in the drug transfer device market. The specialty centers segment is likely to expand at a significant pace owing to the rise in pulmonary diseases, cancers, and hormonal disorders. The specialty center segment is estimated to expand with a substantial CAGR during the forecast period.
Drug Transfer Device Market Regional Outlook
On the basis of regions, the global drug transfer device market is fragmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America holds a major share of the market and this trend is expected to continue during the forecast period. The market in Asia Pacific is projected to expand at a significant CAGR during the forecast period.
The growth of the market in Asia Pacific is attributed to the increasing number of cancer cases and rising demand for improved healthcare services in developing countries such as China and India. The drug transfer devices market is projected to grow due to technological advancements, investments in research & development, and rising awareness about the DTDs among people.
Key Benefits for Industry Participants & Stakeholders
- In-depth analysis of the global drug transfer device market
- Historical, current, and projected market size in terms of value (USD million) and volume (tons)
- Potential & niche segments and regions exhibiting promising growth covered
- Industry drivers, restraints, and opportunities covered in the study
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Neutral perspective on global sulfonated asphalt market performance
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Drug Transfer Device Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Drug Transfer Device Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Drug Transfer Device Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Drug Transfer Device Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Drug Transfer Device Market Size & Volume & Forecast, 2017-2027
4.5.1 Drug Transfer Device Market Size & Volume and Y-o-Y Growth
4.5.2 Drug Transfer Device Market Absolute $ Opportunity
4.6 Global Drug Transfer Device Market: Impact Of Key Regulations
4.7 Medical Devices Industry Outlook
Chapter 5 Global Drug Transfer Device Market Analysis and Forecast By Types
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities By Types
5.1.2 Basis Point Shares (BPS) Analysis By Types
5.1.3 Absolute $ Opportunity Assessment By Types
5.2 Drug Transfer Device Market Size & Volume Forecast By Types
5.2.1 Membrane-to-Membrane Systems
5.2.2 Needleless Systems
5.3 Market Attractiveness Analysis By Types
Chapter 6 Global Drug Transfer Device Market Analysis and Forecast By Components
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities By Components
6.1.2 Basis Point Share (BPS) Analysis By Components
6.1.3 Absolute $ Opportunity Assessment By Components
6.2 Drug Transfer Device Market Size & Volume Forecast By Components
6.2.1 Closed Bag/Line Access Devices
6.2.2 Closed Vial Access Devices
6.2.3 Closed Syringe Safety Devices
6.3 Market Attractiveness Analysis By Components
Chapter 7 Global Drug Transfer Device Market Analysis and Forecast By Technologies
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities By Technologies
7.1.2 Basis Point Share (BPS) Analysis By Technologies
7.1.3 Absolute $ Opportunity Assessment By Technologies
7.2 Drug Transfer Device Market Size & Volume Forecast By Technologies
7.2.1 Diaphragm-Based Devices
7.2.2 Compartmentalized Devices
7.2.3 Air Cleaning/Filtration Devices
7.3 Market Attractiveness Analysis By Technologies
Chapter 8 Global Drug Transfer Device Market Analysis and Forecast By End-Users
8.1 Introduction
8.1.1 Key Market Trends & Growth Opportunities By End-Users
8.1.2 Basis Point Share (BPS) Analysis By End-Users
8.1.3 Absolute $ Opportunity Assessment By End-Users
8.2 Drug Transfer Device Market Size & Volume Forecast By End-Users
8.2.1 Specialty Centers
8.2.2 Hospitals
8.2.3 Clinics
8.2.4 Others
8.3 Market Attractiveness Analysis By End-Users
Chapter 9 Global Drug Transfer Device Market Analysis and Forecast by Region
9.1 Introduction
9.1.1 Key Market Trends & Growth Opportunities by Region
9.1.2 Basis Point Share (BPS) Analysis by Region
9.1.3 Absolute $ Opportunity Assessment by Region
9.2 Drug Transfer Device Market Size & Volume Forecast by Region
9.2.1 North America
9.2.2 Europe
9.2.3 Asia Pacific
9.2.4 Latin America
9.2.5 Middle East & Africa (MEA)
9.3 Market Attractiveness Analysis by Region
Chapter 10 Coronavirus Disease (COVID-19) Impact
10.1 Introduction
10.2 Current & Future Impact Analysis
10.3 Economic Impact Analysis
10.4 Government Policies
10.5 Investment Scenario
Chapter 11 North America Drug Transfer Device Analysis and Forecast
11.1 Introduction
11.2 North America Drug Transfer Device Market Size & Volume Forecast by Country
11.2.1 U.S.
11.2.2 Canada
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 North America Drug Transfer Device Market Size & Volume Forecast By Types
11.6.1 Membrane-to-Membrane Systems
11.6.2 Needleless Systems
11.7 Basis Point Share (BPS) Analysis By Types
11.8 Absolute $ Opportunity Assessment By Types
11.9 Market Attractiveness Analysis By Types
11.10 North America Drug Transfer Device Market Size & Volume Forecast By Components
11.10.1 Closed Bag/Line Access Devices
11.10.2 Closed Vial Access Devices
11.10.3 Closed Syringe Safety Devices
11.11 Basis Point Share (BPS) Analysis By Components
11.12 Absolute $ Opportunity Assessment By Components
11.13 Market Attractiveness Analysis By Components
11.14 North America Drug Transfer Device Market Size & Volume Forecast By Technologies
11.14.1 Diaphragm-Based Devices
11.14.2 Compartmentalized Devices
11.14.3 Air Cleaning/Filtration Devices
11.15 Basis Point Share (BPS) Analysis By Technologies
11.16 Absolute $ Opportunity Assessment By Technologies
11.17 Market Attractiveness Analysis By Technologies
11.18 North America Drug Transfer Device Market Size & Volume Forecast By End-Users
11.18.1 Specialty Centers
11.18.2 Hospitals
11.18.3 Clinics
11.18.4 Others
11.19 Basis Point Share (BPS) Analysis By End-Users
11.20 Absolute $ Opportunity Assessment By End-Users
11.21 Market Attractiveness Analysis By End-Users
Chapter 12 Europe Drug Transfer Device Analysis and Forecast
12.1 Introduction
12.2 Europe Drug Transfer Device Market Size & Volume Forecast by Country
12.2.1 Germany
12.2.2 France
12.2.3 Italy
12.2.4 U.K.
12.2.5 Spain
12.2.6 Russia
12.2.7 Rest of Europe
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Europe Drug Transfer Device Market Size & Volume Forecast By Types
12.6.1 Membrane-to-Membrane Systems
12.6.2 Needleless Systems
12.7 Basis Point Share (BPS) Analysis By Types
12.8 Absolute $ Opportunity Assessment By Types
12.9 Market Attractiveness Analysis By Types
12.10 Europe Drug Transfer Device Market Size & Volume Forecast By Components
12.10.1 Closed Bag/Line Access Devices
12.10.2 Closed Vial Access Devices
12.10.3 Closed Syringe Safety Devices
12.11 Basis Point Share (BPS) Analysis By Components
12.12 Absolute $ Opportunity Assessment By Components
12.13 Market Attractiveness Analysis By Components
12.14 Europe Drug Transfer Device Market Size & Volume Forecast By Technologies
12.14.1 Diaphragm-Based Devices
12.14.2 Compartmentalized Devices
12.14.3 Air Cleaning/Filtration Devices
12.15 Basis Point Share (BPS) Analysis By Technologies
12.16 Absolute $ Opportunity Assessment By Technologies
12.17 Market Attractiveness Analysis By Technologies
12.18 Europe Drug Transfer Device Market Size & Volume Forecast By End-Users
12.18.1 Specialty Centers
12.18.2 Hospitals
12.18.3 Clinics
12.18.4 Others
12.19 Basis Point Share (BPS) Analysis By End-Users
12.20 Absolute $ Opportunity Assessment By End-Users
12.21 Market Attractiveness Analysis By End-Users
Chapter 13 Asia Pacific Drug Transfer Device Analysis and Forecast
13.1 Introduction
13.2 Asia Pacific Drug Transfer Device Market Size & Volume Forecast by Country
13.2.1 China
13.2.2 Japan
13.2.3 South Korea
13.2.4 India
13.2.5 Australia
13.2.6 South East Asia (SEA)
13.2.7 Rest of Asia Pacific (APAC)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Asia Pacific Drug Transfer Device Market Size & Volume Forecast By Types
13.6.1 Membrane-to-Membrane Systems
13.6.2 Needleless Systems
13.7 Basis Point Share (BPS) Analysis By Types
13.8 Absolute $ Opportunity Assessment By Types
13.9 Market Attractiveness Analysis By Types
13.10 Asia Pacific Drug Transfer Device Market Size & Volume Forecast By Components
13.10.1 Closed Bag/Line Access Devices
13.10.2 Closed Vial Access Devices
13.10.3 Closed Syringe Safety Devices
13.11 Basis Point Share (BPS) Analysis By Components
13.12 Absolute $ Opportunity Assessment By Components
13.13 Market Attractiveness Analysis By Components
13.14 Asia Pacific Drug Transfer Device Market Size & Volume Forecast By Technologies
13.14.1 Diaphragm-Based Devices
13.14.2 Compartmentalized Devices
13.14.3 Air Cleaning/Filtration Devices
13.15 Basis Point Share (BPS) Analysis By Technologies
13.16 Absolute $ Opportunity Assessment By Technologies
13.17 Market Attractiveness Analysis By Technologies
13.18 Asia Pacific Drug Transfer Device Market Size & Volume Forecast By End-Users
13.18.1 Specialty Centers
13.18.2 Hospitals
13.18.3 Clinics
13.18.4 Others
13.19 Basis Point Share (BPS) Analysis By End-Users
13.20 Absolute $ Opportunity Assessment By End-Users
13.21 Market Attractiveness Analysis By End-Users
Chapter 14 Latin America Drug Transfer Device Analysis and Forecast
14.1 Introduction
14.2 Latin America Drug Transfer Device Market Size & Volume Forecast by Country
14.2.1 Brazil
14.2.2 Mexico
14.2.3 Rest of Latin America (LATAM)
14.3 Basis Point Share (BPS) Analysis by Country
14.4 Absolute $ Opportunity Assessment by Country
14.5 Market Attractiveness Analysis by Country
14.6 Latin America Drug Transfer Device Market Size & Volume Forecast By Types
14.6.1 Membrane-to-Membrane Systems
14.6.2 Needleless Systems
14.7 Basis Point Share (BPS) Analysis By Types
14.8 Absolute $ Opportunity Assessment By Types
14.9 Market Attractiveness Analysis By Types
14.10 Latin America Drug Transfer Device Market Size & Volume Forecast By Components
14.10.1 Closed Bag/Line Access Devices
14.10.2 Closed Vial Access Devices
14.10.3 Closed Syringe Safety Devices
14.11 Basis Point Share (BPS) Analysis By Components
14.12 Absolute $ Opportunity Assessment By Components
14.13 Market Attractiveness Analysis By Components
14.14 Latin America Drug Transfer Device Market Size & Volume Forecast By Technologies
14.14.1 Diaphragm-Based Devices
14.14.2 Compartmentalized Devices
14.14.3 Air Cleaning/Filtration Devices
14.15 Basis Point Share (BPS) Analysis By Technologies
14.16 Absolute $ Opportunity Assessment By Technologies
14.17 Market Attractiveness Analysis By Technologies
14.18 Latin America Drug Transfer Device Market Size & Volume Forecast By End-Users
14.18.1 Specialty Centers
14.18.2 Hospitals
14.18.3 Clinics
14.18.4 Others
14.19 Basis Point Share (BPS) Analysis By End-Users
14.20 Absolute $ Opportunity Assessment By End-Users
14.21 Market Attractiveness Analysis By End-Users
Chapter 15 Middle East & Africa (MEA) Drug Transfer Device Analysis and Forecast
15.1 Introduction
15.2 Middle East & Africa (MEA) Drug Transfer Device Market Size & Volume Forecast by Country
15.2.1 Saudi Arabia
15.2.2 South Africa
15.2.3 UAE
15.2.4 Rest of Middle East & Africa (MEA)
15.3 Basis Point Share (BPS) Analysis by Country
15.4 Absolute $ Opportunity Assessment by Country
15.5 Market Attractiveness Analysis by Country
15.6 Middle East & Africa (MEA) Drug Transfer Device Market Size & Volume Forecast By Types
15.6.1 Membrane-to-Membrane Systems
15.6.2 Needleless Systems
15.7 Basis Point Share (BPS) Analysis By Types
15.8 Absolute $ Opportunity Assessment By Types
15.9 Market Attractiveness Analysis By Types
15.10 Middle East & Africa (MEA) Drug Transfer Device Market Size & Volume Forecast By Components
15.10.1 Closed Bag/Line Access Devices
15.10.2 Closed Vial Access Devices
15.10.3 Closed Syringe Safety Devices
15.11 Basis Point Share (BPS) Analysis By Components
15.12 Absolute $ Opportunity Assessment By Components
15.13 Market Attractiveness Analysis By Components
15.14 Middle East & Africa (MEA) Drug Transfer Device Market Size & Volume Forecast By Technologies
15.14.1 Diaphragm-Based Devices
15.14.2 Compartmentalized Devices
15.14.3 Air Cleaning/Filtration Devices
15.15 Basis Point Share (BPS) Analysis By Technologies
15.16 Absolute $ Opportunity Assessment By Technologies
15.17 Market Attractiveness Analysis By Technologies
15.18 Middle East & Africa (MEA) Drug Transfer Device Market Size & Volume Forecast By End-Users
15.18.1 Specialty Centers
15.18.2 Hospitals
15.18.3 Clinics
15.18.4 Others
15.19 Basis Point Share (BPS) Analysis By End-Users
15.20 Absolute $ Opportunity Assessment By End-Users
15.21 Market Attractiveness Analysis By End-Users
Chapter 16 Competition Landscape
16.1 Drug Transfer Device Market: Competitive Dashboard
16.2 Global Drug Transfer Device Market: Market Share Analysis, 2019
16.3 Company Profiles (Details - Overview, Financials, Developments, Strategy)
16.3.1 B. Braun Medical Inc.
16.3.2 BD
16.3.3 Caragen Ltd.
16.3.4 Corvida Medical
16.3.5 Epic Medical
16.3.6 Equashield LLC.
16.3.7 ICU Medical, Inc.
16.3.8 JMS Co Ltd
16.3.9 Simplivia Healthcare
16.3.10 West Pharmaceutical
16.3.11 Yukon Medical
16.3.12 Company 12
16.3.13 Company 13
16.3.14 Company 14
16.3.15 Company 15